Literature DB >> 35739357

H2B Lys34 Ubiquitination Induces Nucleosome Distortion to Stimulate Dot1L Activity.

Huasong Ai1, Maoshen Sun1, Aijun Liu2,3, Zixian Sun2, Tingting Liu4, Lin Cao2,5, Lujun Liang1, Qian Qu1, Zichen Li1, Zhiheng Deng1, Zebin Tong1, Guochao Chu1, Xiaolin Tian6, Haiteng Deng6, Suwen Zhao4,7, Jia-Bin Li8, Zhiyong Lou9, Lei Liu10.   

Abstract

Ubiquitination-dependent histone crosstalk plays critical roles in chromatin-associated processes and is highly associated with human diseases. Mechanism studies of the crosstalk have been of the central focus. Here our study on the crosstalk between H2BK34ub and Dot1L-catalyzed H3K79me suggests a novel mechanism of ubiquitination-induced nucleosome distortion to stimulate the activity of an enzyme. We determined the cryo-electron microscopy structures of Dot1L-H2BK34ub nucleosome complex and the H2BK34ub nucleosome alone. The structures reveal that H2BK34ub induces an almost identical orientation and binding pattern of Dot1L on nucleosome as H2BK120ub, which positions Dot1L for the productive conformation through direct ubiquitin-enzyme contacts. However, H2BK34-anchored ubiquitin does not directly interact with Dot1L as occurs in the case of H2BK120ub, but rather induces DNA and histone distortion around the modified site. Our findings establish the structural framework for understanding the H2BK34ub-H3K79me trans-crosstalk and highlight the diversity of mechanisms for histone ubiquitination to activate chromatin-modifying enzymes.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35739357     DOI: 10.1038/s41589-022-01067-7

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   16.174


  49 in total

Review 1.  Histone and chromatin cross-talk.

Authors:  Wolfgang Fischle; Yanming Wang; C David Allis
Journal:  Curr Opin Cell Biol       Date:  2003-04       Impact factor: 8.382

Review 2.  Chromatin modifications and their function.

Authors:  Tony Kouzarides
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

Review 3.  Crosstalk among Histone Modifications.

Authors:  Tamaki Suganuma; Jerry L Workman
Journal:  Cell       Date:  2008-11-14       Impact factor: 41.582

4.  Monoubiquitination of human histone H2B: the factors involved and their roles in HOX gene regulation.

Authors:  Bing Zhu; Yong Zheng; Anh-Dung Pham; Subhrangsu S Mandal; Hediye Erdjument-Bromage; Paul Tempst; Danny Reinberg
Journal:  Mol Cell       Date:  2005-11-23       Impact factor: 17.970

5.  MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L.

Authors:  Kathrin M Bernt; Nan Zhu; Amit U Sinha; Sridhar Vempati; Joerg Faber; Andrei V Krivtsov; Zhaohui Feng; Natalie Punt; Amanda Daigle; Lars Bullinger; Roy M Pollock; Victoria M Richon; Andrew L Kung; Scott A Armstrong
Journal:  Cancer Cell       Date:  2011-07-12       Impact factor: 31.743

6.  Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia.

Authors:  Eric Wang; Shinpei Kawaoka; Ming Yu; Junwei Shi; Ting Ni; Wenjing Yang; Jun Zhu; Robert G Roeder; Christopher R Vakoc
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-14       Impact factor: 11.205

Review 7.  Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond.

Authors:  Chun-Wei Chen; Scott A Armstrong
Journal:  Exp Hematol       Date:  2015-06-25       Impact factor: 3.084

8.  H3K79 methylation profiles define murine and human MLL-AF4 leukemias.

Authors:  Andrei V Krivtsov; Zhaohui Feng; Madeleine E Lemieux; Joerg Faber; Sridhar Vempati; Amit U Sinha; Xiaobo Xia; Jonathan Jesneck; Adrian P Bracken; Lewis B Silverman; Jeffery L Kutok; Andrew L Kung; Scott A Armstrong
Journal:  Cancer Cell       Date:  2008-11-04       Impact factor: 31.743

Review 9.  Readout of epigenetic modifications.

Authors:  Dinshaw J Patel; Zhanxin Wang
Journal:  Annu Rev Biochem       Date:  2013       Impact factor: 23.643

10.  Gene silencing: trans-histone regulatory pathway in chromatin.

Authors:  Scott D Briggs; Tiaojiang Xiao; Zu-Wen Sun; Jennifer A Caldwell; Jeffrey Shabanowitz; Donald F Hunt; C David Allis; Brian D Strahl
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.